WASHINGTON — U.S. health officials are investigating low levels of a potentially dangerous contaminant in the popular heartburn medication Zantac and related drugs. For now, the Food and Drug Administration said patients can continue taking their medications. The agency said Friday it has detected a “probable” cancer-causing chemical in the medications, which are sold as
